about
CD74 in Kidney DiseaseHorizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadeTWEAK and the progression of renal disease: clinical translationAcute kidney injury transcriptomics unveils a relationship between inflammation and ageingTWEAK promotes peritoneal inflammationIdentification of a potent endothelium-derived angiogenic factorHSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin IITWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL212017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsTNF superfamily: a growing saga of kidney injury modulators.MXRA5 is a TGF-β1-regulated human protein with anti-inflammatory and anti-fibrotic propertiesInflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease.BASP1 promotes apoptosis in diabetic nephropathy.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Does wealth make health? Cherchez la renal replacement therapy.Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urineA combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI.Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?Modifiable risk factors for increased arterial stiffness in outpatient nephrologyTweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasiaThrombotic microangiopathy: expanding genetic, clinical and therapeutic spectra and the need for worldwide implementation of recent advancesAlbumin-induced apoptosis of tubular cells is modulated by BASP1.The cytokine TWEAK modulates renal tubulointerstitial inflammation.Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsA slit in podocyte death.Deferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells.NF-kappaB in renal inflammation.TWEAK and the kidney: the dual role of a multifunctional cytokine.TWEAK, a multifunctional cytokine in kidney injury.2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials.MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled.Progress in the development of animal models of acute kidney injury and its impact on drug discovery.Macrophages and recently identified forms of cell death.Unilateral ureteral obstruction: beyond obstruction.TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney DiseaseOsteoprotegerin and kidney disease.Next-generation phosphate binders: focus on iron-based binders.
P50
Q26781254-9DE3D3F0-E2AB-4A19-853F-5550CCE9D699Q26799443-983ED2C8-08F6-4275-A5D3-AD2D9888F6FCQ26996775-2029D264-FFCB-4DB3-A30F-A42F22AF86D4Q27023602-A62DEC7B-05EC-49FF-834A-B06F6B9CE10FQ27318227-49744F40-6EFB-4D1F-BBC8-2EB4F8F5C93EQ28534947-6E3060BD-4FFB-4A94-8A7C-9CBA0F3A0E68Q28578531-2C709CA1-DA26-4590-9508-8D7109F66859Q28749137-B589D2BF-8CD7-4821-BCF7-144FE090844EQ30239808-60534A44-8D4F-45B1-8147-E96CA3122F7BQ30479123-0B7C27F6-3CFF-499E-9116-156349A4B885Q33112694-18612E83-8C1B-4C92-A76F-E9997D8FFB2AQ33611989-66DBEB9D-DCB4-4623-9586-BDA647AC472DQ33646324-99428A27-6E1A-4CD1-B84C-4F3DD7365020Q33748559-217C8211-4E6B-40B0-95A2-83FF4BC074FCQ33749467-BCDE8114-3555-4484-BC21-EFF611CD8473Q33793469-738091CF-C7FC-46A2-AD04-07FCE9738D8BQ34450860-CE081470-CEE3-4769-A472-04FF35C565DFQ34994210-D9212CBF-CC94-4254-8688-E4F80E41D0DCQ35029014-8E4CFCF2-46FE-4ED8-944A-78CE62BB63B1Q35232161-ADD479C9-0F0A-401E-98BF-106E847686EAQ35448958-2F94C977-7DE8-4982-800A-78C33E92358EQ35893298-BE8EE20A-60FE-4316-9748-1BE9E4FAAE20Q36306802-3518E945-F666-40D2-A7E0-395B3665C715Q36347210-FEC167B3-9CA1-4901-812C-6C6D1B463823Q36666882-79563D90-53AB-4F3C-9093-797D231F5305Q37113004-8C00F88E-9805-4D3E-BF0F-D3C9162BDD69Q37232965-9179B69B-B1DD-46E2-AA12-F21A2C397B5AQ37615232-6C6761FA-A221-4289-82EA-D7925B6CCCC7Q37774798-A7114AA3-0577-422A-B763-406E138F2B5FQ37820359-3BF1AEB8-102D-4009-9565-028B2CC64EF6Q37893443-5EC364E4-BF3E-4AE3-8B43-B7D2F52A97CBQ38027004-348DDDDC-CAA2-43F9-A4FD-79160F695717Q38041830-1FAB108C-193F-4044-94A2-DA9674F8EB1BQ38042361-5A21AA96-F87A-4725-BA12-6398162320F9Q38102743-C05094F3-961C-4099-94E5-D9F138EB68BCQ38117151-A074DBAF-C220-4810-93E5-609EB67283F1Q38144939-C8762AA6-3804-42E4-B9DC-8BBC0B18A4C5Q38171480-352430F6-B394-4187-92C8-12757CD89860Q38206487-0B6FD76F-E84F-4054-BB3E-A74F35B780D9Q38213502-DAC5773F-287E-4EBC-87D2-6A3F45AC030E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria Dolores Sanchez-niño
@ast
Maria Dolores Sanchez-niño
@en
Maria Dolores Sanchez-niño
@es
Maria Dolores Sanchez-niño
@nl
Maria Dolores Sanchez-niño
@sl
type
label
Maria Dolores Sanchez-niño
@ast
Maria Dolores Sanchez-niño
@en
Maria Dolores Sanchez-niño
@es
Maria Dolores Sanchez-niño
@nl
Maria Dolores Sanchez-niño
@sl
altLabel
Maria Dolores Sanchez-Niño
@en
prefLabel
Maria Dolores Sanchez-niño
@ast
Maria Dolores Sanchez-niño
@en
Maria Dolores Sanchez-niño
@es
Maria Dolores Sanchez-niño
@nl
Maria Dolores Sanchez-niño
@sl
P1053
B-7350-2019
P106
P1153
57202569015
P21
P31
P496
0000-0001-7110-6409